Palantir Technologies (NASDAQ: PLTR) posted second-quarter revenue of $1.94 billion on Monday, up 93% year-on-year (YoY) and well ahead of Wall Street’s $1.81 billion estimate. Adjusted earnings reached $0.41 a share against a $0.35 forecast. It was the company’s ninth straight quarter above analyst expectations and the second consecutive quarter in which management raised full-year guidance. Shares rose 12% in after-hours trading and extended gains on Tuesday, climbing as much as 20%, though the stock remains well down year-to-date.
Institutional investors must now weigh accelerating fundamentals against a valuation the market has been reluctant to reward.
Why Disruption Banking Has Been Sceptical Since February
That tension is not new. Disruption Banking has tracked it since February, when we asked whether Palantir’s dependence on government and defence contracts, combined with a rich multiple, had made the company too big to fail for its own shareholders. The same coverage flagged a separate political risk: Palantir’s £330 million NHS data contract in Britain, which remains under pressure from MPs and campaigners. A subsequent PLTR stock sell-off in April, triggered by Michael Burry’s public critique of the valuation and rising competition from rivals such as Anthropic, showed how quickly sentiment can turn even after repeated stronger-than-expected results.
PLTR Earnings Put Commercial Growth at Centre Stage
Monday’s numbers offer the clearest counter to that scepticism so far. U.S. commercial revenue, the segment investors watch for proof that Palantir can expand beyond government work, jumped 149% YoY to $764 million. Total U.S. revenue rose 115% to $1.573 billion and accounted for just over 81% of group revenue. The faster commercial sales grow relative to government work, the less Palantir’s fortunes will hinge on individual state contracts. “Our Q2 results are unprecedented, but entirely unsurprising,” chief revenue officer Ryan Taylor said during the earnings call.
Management lifted full-year 2026 revenue guidance to between $8.150 billion and $8.158 billion, implying 82% growth for the year. CEO Alex Karp dismissed valuation sceptics directly, telling CNBC that no business at Palantir’s scale has grown anywhere near this fast.
Palantir Stock Still Faces a Valuation Test
None of that resolves the underlying debate. Palantir still trades at a price-to-sales ratio well above that of most software peers, and one strong quarter cannot, by itself, justify a multiple built on years of sustained hypergrowth. However, Palantir’s Rule of 40 score reached 155%, far above the level fund managers generally consider healthy. That shows its growth is not coming at the expense of profitability. The results shift the burden of proof back onto the bears, at least until the next quarter tests whether this pace can hold.
What Comes Next for the PLTR Stock Price
For institutional investors, the practical question has moved on from whether Palantir can grow. It clearly can. The open question is whether the market will pay for that growth at the current valuation, or whether Monday’s rally simply resets the argument for another quarter. Management’s signal is confidence: third-quarter revenue guidance of $2.160 billion to $2.164 billion would keep growth above 80% for a third consecutive quarter if achieved.
Author: Richardson Chinonyerem
The editorial team at #DisruptionBanking has taken all precautions to ensure that no persons or organisations have been adversely affected or offered any sort of financial advice in this article. This article is most definitely not financial advice.
See Also:
Why Palantir (PLTR) Dropped Over 8% Today as Michael Burry Renews Anthropic Critique
